Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancer

16 Sept 2015

Abstract excerpt

BACKGROUND: A number of clinico-pathological criteria and molecular profiles have been used to stratify patients into high- and low-risk groups. Currently, there are still no effective methods to determine which patients harbor micrometastatic disease after standard breast cancer therapy and who will eventually develop local or distant recurrence. The purpose of our study was to identify circulating DNA...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 26380585
DOI: 10.1186/s13148-015-0135-8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Whole-genome bisulfite sequencing of cell-free DNA identifies signature associated with metastatic breast cancerPMID 26380585Read ↗

Whole‐genome bisulfite sequencing analysis of circulating tumour DNA for the detection and molecular classification of cancerSemantic proximity Read ↗

Novel Methylated Biomarkers and a Robust Assay to Detect Circulating Tumor DNA in Metastatic Breast CancerSemantic proximity Read ↗

Differential methylation of circulating free DNA assessed through cfMeDiP as a new tool for breast cancer diagnosis and detection of BRCA1/2 mutation.Semantic proximity Read ↗

DNA damage response as a prognostic indicator in metastatic breast cancer via mutational analysisSemantic proximity Read ↗

A seven-gene CpG-island methylation panel predicts breast cancer progressionSemantic proximity Read ↗

DNA methylation biomarkers for the diagnosis and treatment management of breast cancer: where are we now?Semantic proximity Read ↗

Multigene methylation analysis of enriched circulating tumor cells associates with poor progression-free survival in metastatic breast cancer patientsSemantic proximity Read ↗

Blood DNA methylation and breast cancer risk: a prospective nested case-control study.Semantic proximity Read ↗

A DNA Methylation-Based Test for Breast Cancer Detection in Circulating Cell-Free DNASemantic proximity Read ↗

Circulating cell-free DNA-based epigenetic assay can detect early breast cancerSemantic proximity Read ↗

Circulating tumor cells: from new biological insights to clinical practiceSemantic proximity Read ↗

Detection of microsatellite instability high (MSI-H) status by targeted plasma-based genotyping in metastatic breast cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.